Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Report Offers Creative Solutions to Rural Mental Health Care Obstacles
12/02/2021
Jolynn Tumolo
SMI Adviser, in partnership with the NASMHPD and the NASMHPD Research Institute, has published a report on how to improve the availability, accessibility, and acceptability of mental health care in rural and remote areas.
SMI Adviser, in partnership with the NASMHPD and the NASMHPD Research Institute, has published a report on how to improve the availability, accessibility, and acceptability of mental health care in rural and remote areas.
SMI Adviser, in partnership with...
12/02/2021
Psych Congress Network
News
Schizophrenia Codes for Nursing Home Patients With Dementia Grew After Antipsychotic Reporting Began
12/01/2021
Jolynn Tumolo
After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...
After the implementation of the CMS public reporting of nursing home antipsychotic use, the proportion of residents with different forms of dementia also diagnosed with schizophrenia increased — and more so among patients who were Black...
After the implementation of the...
12/01/2021
Psych Congress Network
News
Combined Intervention Shows Promise for Easing Negative Symptoms of Psychosis
12/01/2021
Jolynn Tumolo
New research shows an intervention combining CBSST-CCT improved negative symptoms and verbal learning in adults with schizophrenia.
New research shows an intervention combining CBSST-CCT improved negative symptoms and verbal learning in adults with schizophrenia.
New research shows an...
12/01/2021
Psych Congress Network
News
In Real-World Setting, Treatment Efficacy for CML in Line With Promising Recent Data
12/01/2021
Jolynn Tumolo
Researchers concluded that asciminib was safe and effective in patients with chronic myeloid leukemia who did not benefit from alternative treatments in clinical practice.
Researchers concluded that asciminib was safe and effective in patients with chronic myeloid leukemia who did not benefit from alternative treatments in clinical practice.
Researchers concluded that...
12/01/2021
First Report Managed Care
News
Smartphone App Reduces Symptoms in Users With Serious Mental Illness
11/29/2021
Jolynn Tumolo
A smartphone app designed to challenge dysfunctional beliefs in people with serious mental illness reduced symptoms of depression and anxiety as well as functional impairment.
A smartphone app designed to challenge dysfunctional beliefs in people with serious mental illness reduced symptoms of depression and anxiety as well as functional impairment.
A smartphone app designed to...
11/29/2021
Psych Congress Network
News
Migraine History Appears to Increase Risk for Peripartum Depression and Anxiety
11/24/2021
Jolynn Tumolo
A history of migraine may be a risk factor for anxiety symptoms in mid-pregnancy and for mixed symptoms of depression and anxiety in later stages of pregnancy, according to a study published in the Journal of Affective Disorders.
A history of migraine may be a risk factor for anxiety symptoms in mid-pregnancy and for mixed symptoms of depression and anxiety in later stages of pregnancy, according to a study published in the Journal of Affective Disorders.
A history of migraine may be a...
11/24/2021
Psych Congress Network
News
Topical Corticosteroid Recalled
11/24/2021
Jolynn Tumolo
A prescription corticosteroid used to treat eczema, dermatitis, and other skin conditions is under a Class II recall.
A prescription corticosteroid used to treat eczema, dermatitis, and other skin conditions is under a Class II recall.
A prescription corticosteroid...
11/24/2021
Pharmacy Learning Network
News
Hypertension Patches Recalled
11/24/2021
Jolynn Tumolo
The FDA issued a Class III recall for a prescription medication used to treat high blood pressure.
The FDA issued a Class III recall for a prescription medication used to treat high blood pressure.
The FDA issued a Class III...
11/24/2021
Pharmacy Learning Network
News
Class I, II Recalls for OTC Antifungal Sprays
11/24/2021
Jolynn Tumolo
Several lots of antifungal sprays have been voluntarily recalled due to the presence of benzene, a human carcinogen, in product samples.
Several lots of antifungal sprays have been voluntarily recalled due to the presence of benzene, a human carcinogen, in product samples.
Several lots of antifungal...
11/24/2021
Pharmacy Learning Network
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
November 6 ⁠–⁠ November 8
NEI Congress
November 7 ⁠–⁠ November 10
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use